Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bariatric Surgery Shows Promise In Preventing Type 2 Diabetes

This article was originally published in The Gray Sheet

Executive Summary

At 15 years of follow-up in the Swedish Obese Subjects study, 110 bariatric surgery patients had developed type 2 diabetes versus 392 non-surgery patients in the control group, corresponding to incidence rates of 6.8 cases and 28.4 cases per 1,000 person-years, respectively.

You may also be interested in...



Cleveland Clinic’s ‘Top 10’ Picks For 2013 Include Eight Device-Related Innovations

Renowned academic medical center unveils its annual ‘top 10’ list of medical innovations it anticipates will have a major impact on patient care within the next year, including eight that are device-related.

Bariatric Surgery Bests Medical Therapy In Treating Diabetes

The findings come from two studies, including the randomized STAMPEDE trial, funded by Johnson & Johnson and the National Institutes of Health, comparing medical therapy with two forms of surgical treatment – gastric bypass or sleeve gastrectomy.

Amneal Eyes Avastin And Praises $120m Biosimilar Development Savings

Amneal is close to a filed pipeline of three biosimilar products in the US, while furthering ambitions in the complex generics and 505(b)(2) space, management told the virtual J.P. Morgan Healthcare Conference.

Topics

UsernamePublicRestriction

Register

OM017175

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel